The Role of Immune-Related Adverse Events in Prognosis and Efficacy Prediction for Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: A Retrospective Clinical Analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33631764/

doi: 10.1159/000511999. Online ahead of print. 1 First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan. 2 First Department of Internal Medicine, Shinshu University School of Medicine,...

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy

Source : https://link.springer.com/article/10.1245/s10434-021-09690-9

Purpose Current evidence suggests that the neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in several types of cancer. In this study, we aimed to evaluate the prognostic impact of clinicopathological...

Systemic immune–inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy

Source : https://www.futuremedicine.com/doi/abs/10.2217/fon-2020-1272

cookie policy. ×

Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893565/

Cell-free DNA (cfDNA) in supernatant of pleural effusion from advanced NSCLC patients has been proved as surrogate sample detecting therapeutic targets as well as tumor mutation burden (TMB). As recently...

Serum macrophage inhibitory cytokine‐1 as a clinical marker for non-small cell lung cancer

Source : https://onlinelibrary.wiley.com/doi/full/10.1111/jcmm.16360

Chunhua Xu Corresponding Author Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China Correspondence Chunhua Xu, Department of Respiratory Medicine, The...